Statewide CPR and EMS program does not raise cardiac arrest survival; AI model predicts ROSC from end-tidal CO2; breathing tubes recalled

Two defibrillator paddles resting side by side on a steel cart, their coiled cords looping away.

A community and emergency medical services program across North Carolina counties did not raise survival with good neurologic outcome after out-of-hospital cardiac arrest, 9.0% versus 9.4%, in a trial published Nov. 8.

An AI model predicted return of spontaneous circulation from end-tidal carbon dioxide but needs recalibration, the Food and Drug Administration (FDA) flagged breathing tubes that may disconnect and coated guidewires that may shed emboli, and FDA approved asundexian after mild-to-moderate ischemic stroke.

  • Research Nov 8, 2026
    In the registry-based, cluster-randomized RACE-CARS trial in North Carolina, published Nov. 8 in NEJM and presented at the American Heart Association Scientific Sessions, survival to discharge with good neurologic outcome was 9.0% with a program of 911 telecommunicator training, community CPR training and expanded early defibrillator use versus 9.4% with usual care (adjusted odds ratio 0.97, 95% CI 0.75 to 1.26; P = .80). The trial assigned 11,615 patients to the intervention and 10,844 to usual care. The program did not improve overall bystander CPR rates, 44.8% in intervention communities versus 42.3%, according to the American Heart Association.
  • AI Nov 12, 2026
    A two-layer long short-term memory model estimated the probability of return of spontaneous circulation (ROSC) in the next 2-minute cycle from end-tidal carbon dioxide trends in 1,651 events among 1,480 adults with out-of-hospital cardiac arrest, according to a multicenter retrospective study published Nov. 12 in Resuscitation. The area under the curve was 0.876 at the event level but 0.685 when applied at each cycle, where the model overestimated ROSC probability. Performance came from 10-fold cross-validation, and the authors said recalibration is required before cycle-to-cycle use.
  • FDA Nov 10, 2026
    The Food and Drug Administration (FDA) on Nov. 10 posted an early alert on Intersurgical 22mm Smoothbore breathing tubes and systems, some of which were manufactured with too little solvent to ensure a secure connection. A connector that disconnects during use could cause loss of ventilation and potentially organ failure, brain damage or death from hypoxia. Intersurgical's Nov. 3 letter told customers to immediately stop using and quarantine affected lots; the company reported no serious injuries or deaths as of Nov. 3.
    Source: FDA
  • FDA Nov 10, 2026
    The Food and Drug Administration (FDA) on Nov. 10 posted an early alert on Arrow International hydrophilic-coated guidewires and pressure-injectable catheters that contain them, after Teleflex confirmed the coating may swell inconsistently when hydrated with saline, leading to clumping and potential detachment. Hydrophilic polymer emboli may cause inflammation, thrombosis, ischemia, tissue injury, stroke or death. The company's Nov. 5 letter told customers to stop use and quarantine affected product; it reported no serious injuries or deaths.
    Source: FDA
  • FDA Nov 9, 2026
    The Food and Drug Administration (FDA) on Nov. 9 approved Sunharbo (asundexian), the first factor XIa inhibitor, for use with antiplatelet therapy after a recent mild-to-moderate non-cardioembolic ischemic stroke or high-risk transient ischemic attack. In the phase 3 trial of 12,327 adults randomized within 72 hours of symptom onset, it cut ischemic stroke 26% versus placebo, with similar overall major bleeding, according to FDA. It should be withheld for at least 24 hours after thrombolysis for acute ischemic stroke and is not approved for atrial fibrillation.
    Source: FDA
  • Public health Nov 13, 2026
    The Pan American Health Organization (PAHO) has revoked the measles elimination status of the United States, according to a Wall Street Journal report cited by Reuters on Nov. 13, Contagion Live reported; PAHO did not immediately respond to a request for comment on the report. Reuters had reported Nov. 11 that the determination was expected to be made public early the following week. The Centers for Disease Control and Prevention (CDC) reported 5,412 confirmed cases in 2026 as of Nov. 12; its website lists six deaths, while state health departments have reported 10, according to Contagion Live.

The weekly innovation roundup for emergency medicine, published every Sunday for the week before; every item links to its sources. Latest emergency medicine news · All specialties

Latest news

Tagged emergency medicine, from the daily briefing

  1. Congo's Ebola outbreak passes 11,000 cases and 5,387 deaths, and the strain behind it has no known vaccine
  2. One in 10 patients given andexanet for factor Xa inhibitor bleeding had a clot, and restarting anticoagulation lowered the risk
  3. Meta-analysis compares length-based tapes with other tools for weight estimation and dosing in pediatric resuscitation

See all the latest news